Teladoc Health Held In-Line Rating in Late Ocotber as Evercore Reversed Price Target Back to $8

Teladoc Health, Inc. (NYSE:TDOC) is one of the best digital health stocks to buy now.

In October 2025, Evercore ISI analyst Elizabeth Anderson issued two ratings on Teladoc Health, both times maintaining an In-Line stance while adjusting the firm’s price target in opposite directions. On October 8, Anderson raised the price target from $8.00 to $9.00. Three weeks later, on October 30, she reversed that move following the company’s Q3 earnings call, lowering the target back to $8.00. No additional commentary was made publicly available alongside either rating.

Teladoc Health announced Q3 results on October 29. Revenue dipped because BetterHelp shrank while Teladoc pulled back on performance marketing and pushed insurance acceptance, and access fees softened. Integrated Care grew, but the mix still hurt profitability: BetterHelp’s 1.6% margin versus Integrated Care’s 17.0% meant an 8% decline in the lower-margin segment pulled group adjusted EBITDA down 16% to $69.9M.

Wichy/Shutterstock.com

The GAAP loss widened largely due to non-cash charges and amortization, not collapsing demand. International growth of 12% partly offset a 5% U.S. decline. Guidance implies discipline: modest Integrated Care growth with mid-teens margins, and a slow BetterHelp rebuild as channels reset and insurance adoption trades near-term revenue for durability.

Teladoc Health, Inc. (NYSE:TDOC) is a virtual care company that offers telehealth services across a range of clinical areas including general medicine, mental health, and chronic condition management. It operates through a platform that integrates clinicians, AI, and analytics to deliver care remotely.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None.